The citric acid cycle is central to the regulation of energy homeostasis and cell metabolism 1 . Mutations in enzymes that catalyse steps in the citric acid cycle result in human diseases with various clinical presentations 2 . The intermediates of the citric acid cycle are present at micromolar concentration in blood and are regulated by respiration, metabolism and renal reabsorption/ extrusion. Here we show that GPR91 (ref. 3) , a previously orphan G-protein-coupled receptor (GPCR), functions as a receptor for the citric acid cycle intermediate succinate. We also report that GPR99 (ref. 4 ), a close relative of GPR91, responds to a-ketoglutarate, another intermediate in the citric acid cycle. Thus by acting as ligands for GPCRs, succinate and a-ketoglutarate are found to have unexpected signalling functions beyond their traditional roles. Furthermore, we show that succinate increases blood pressure in animals. The succinate-induced hypertensive effect involves the renin-angiotensin system and is abolished in GPR91-deficient mice. Our results indicate a possible role for GPR91 in renovascular hypertension, a disease closely linked to atherosclerosis, diabetes and renal failure 5, 6 .
In a search for natural ligands for orphan GPCRs, we tested extracts from various animal tissues for their ability to evoke an increase in intracellular Ca 2þ concentration ([Ca 2þ ] i ) using the aequorin assay 7 . We found that fractions from pig kidney extracts specifically activated cells expressing GPR91 (Fig. 1a) . GPR91 is an orphan GPCR highly expressed in the kidney and shares 33% amino acid identity with GPR99/GPR80 (refs 4, 8) . On the basis of their homology with the purinergic receptor P2Y1, nucleotide ligands were predicted for GPR91 and GPR99 (ref. 4) . However, the GPR91 ligand activity in pig kidney extracts was resistant to various stringent treatments including alkaline phosphatase, peptidase, and hydrolysis in 6 M HCl at 100 8C. Accordingly, the supposition that GPR91 might be activated by a nucleotide or peptide ligand was unlikely. We purified the natural ligand for GPR91 by ion-exchange, size-exclusion and reversed-phase fast performance liquid chromatography/high-performance liquid chromatography (Fig. 1a) .
A major molecular ion [M þ H] þ at m/z 119.2 was observed by mass spectrometry (Fig. 1b) .
1 H NMR analysis revealed a single type of proton in the highly purified GPR91 ligand (Fig. 1c) . 13 C NMR analysis further suggested the presence of -CH 2 -(methylene) and ¼C¼O (carbonyl) groups (Fig. 1d) . Combined with mass spectrometry results and the biochemical properties of the ligand, the purified GPR91 ligand was predicted and confirmed to be succinic acid (Fig. 1c, d ).
Commercially obtained succinate (the physiological form of succinic acid) increased [Ca 2þ ] i dose-dependently in the aequorin assay (Fig. 2a) . Succinate also activated mouse and rat orthologues of GPR91 (Fig. 2a) . The succinate-induced increase in [Ca 2þ ] i was further confirmed with a fluorimetric imaging plate reader (FLIPR) system in the 293-hGPR91 cell line (293 cells stably expressing human GPR91) (Fig. 2b) . The concentration giving half-maximal response (EC 50 ) for succinate-induced activation of human GPR91 was 56^8 mM in the aequorin assay and 28^5 mM in the FLIPR assay. GPR91 was selectively activated by succinate but not by other citric acid cycle intermediates (Supplementary Information) or any of a collection of 800 pharmacologically active compounds and known GPCR ligands tested (data not shown). Furthermore, of 200 letters to nature carboxylic acids and structurally related analogues, succinate was found to be the most potent in increasing [Ca 2þ ] i (a representative subset is summarized in Supplementary Information).
Because GPR99 is the closest homologue of GPR91, we proposed that other citric acid cycle intermediates and carboxylic acids might activate GPR99. We identified a-ketoglutarate as a ligand for human GPR99, with an EC 50 of 69^11 mM in the aequorin assay (Fig. 2c ) and 32^4 mM in the FLIPR assay (Fig. 2d) . a-Ketoglutarate also activated mouse GPR99 (Fig. 2c) . Neither succinate nor a-ketoglutarate activated calcium mobilization with about 30 GPCRs unrelated to GPR91 and GPR99 (data not shown).
To dissect the signalling pathways of GPR91 and GPR99, various biochemical assays were investigated. Succinate inhibited forskolinstimulated cAMP production in 293-hGPR91 cells, an effect abolished by preincubation with pertussis toxin (PTX) (Fig. 2e) . In addition, succinate induced the accumulation of inositol phosphate in 293-hGPR91 cells (Fig. 2f) . The succinate-induced accumulation of inositol phosphate and an increase in [Ca 2þ ] i were each partly inhibited by pertussis toxin (Fig. 2f and Supplementary Information). Moreover, succinate activated extracellular signal-regulated kinase (Erk) in 293-hGPR91 cells (Supplementary Information). Taken together, these results suggest that GPR91 activation by succinate couples to at least two signalling pathways, a pertussis-toxin-sensitive G i /G o pathway and a pertussis-toxininsensitive G q pathway. Similarly, a-ketoglutarate stimulated inositol phosphate formation in a GPR99-dependent manner (Fig. 2g ).
Because GPR99 activation did not affect cAMP levels (data not shown), and both inositol phosphate formation ( Fig. 2g ) and [Ca 2þ ] i flux (Supplementary Information) were found to be insensitive to pertussis toxin, GPR99 seems to act exclusively through a G q -mediated pathway.
Ligand-induced receptor internalization is often characteristic of GPCR activation and signal attenuation 9 . Immunofluorescent staining of cells expressing Flag-tagged GPR91 or GPR99 revealed that both GPR91 and GPR99 were localized to the plasma membrane (Fig. 2h) . Ligand stimulation induced the internalization of both receptors (Fig. 2h) .
Because the dicarboxylate groups of succinate and a-ketoglutarate are required for the activation of GPR91 and GPR99, we speculated that basic residues of GPR91 and GPR99 might be important in binding dicarboxylate ligands. A partial three-dimensional model of GPR91 was generated. Mutation of Arg 99, His 103, Arg 252 or Arg 281 (Supplementary Information) abolished GPR91 activation by succinate, whereas mutation of His 249, Arg 255 or Tyr 107 had no effect on receptor function (Fig. 3a) . Various GPR91 mutants were expressed at similar levels ( Fig. 3b ) and localized at the plasma membrane (data not shown). All four residues required for GPR91 activation by succinate (Arg 99, His 103, Arg 252 and Arg 281) are directed into the central cavity where cis-retinal binds in the rhodopsin structure ( Fig. 3c, d ). These four positively charged residues cluster together, Arg 99 and His 103 of helix III on one side and Arg 252 of helix VI and Arg 281 of helix VII on the other side, letters to nature and may provide a unique electrostatic complementary binding environment for succinate (Fig. 3d) . A comparison of about 300 family A GPCRs revealed that GPR91 and GPR99 uniquely contain all four basic residues, suggesting that GPR91 and GPR99 are specialized receptors for dicarboxylate ligands. Expression analysis by quantitative reverse-transcriptasemediated polymerase chain reaction (Q-RT-PCR) revealed that the GPR91 and GPR99 messenger RNAs were each predominantly expressed in the kidney, with limited expression in other tissues (GPR91 in the liver and the spleen, and GPR99 in the testis and the smooth muscle; Fig. 4a, b and refs 3, 4) . In situ hybridization experiments indicated specific GPR91 and GPR99 expression in the cortical region of the mouse kidney (Fig. 4c) . GPR91 was detected mainly in the proximal tubules, as demonstrated by the presence of a prominent brush border projecting into the lumen on periodicacid-Schiff-stained adjacent sections (Fig. 4d) . GPR91 was also found, to a smaller extent, in the distal tubules (revealed by staining with antibodies against the distal-tubule marker calbindin 10 ; Fig. 4d ) and the juxtaglomerular apparatus (Supplementary Information). In contrast, GPR99 was found predominantly in the distal tubules (Fig. 4e, f) .
Intravenous injection of succinate into Sprague-Dawley rats increased plasma renin activity (Fig. 5a) , which is consistent with a previous report that succinate-treated kidney cultures ex vivo released renin 11 . Renin is a key enzyme in the renin-angiotensin system, which is essential in blood pressure regulation 12, 13 . Cumulative intravenous administration of succinate produced a dosedependent increase in mean arterial pressure (MAP) (Fig. 5b) . Bilateral nephrectomy completely abolished this effect (Fig. 5c) , demonstrating the kidney as the primary site of action. To dissect the pharmacological mechanism for succinate-induced hypertension, the angiotensin-converting enzyme inhibitor captopril was used. Pretreatment with captopril significantly attenuated the hypertensive effect of succinate (Fig. 5d) , indicating that the angiotensin-converting enzyme product(s) might mediate hypertension induced by succinate. In contrast, neither nephrectomy nor captopril treatment had any effect on angiotensin II-induced hypertension (Fig. 5c, d) .
To further explain the mechanisms underlying succinate-induced hypertension, we generated GPR91-deficient mice by homologous recombination (Fig. 5e, f) . Mice homozygous for the targeted allele of GPR91 are viable and have no discernable phenotype. The systolic blood pressures and heart rates were similar in unanaesthetized wild-type and GPR91-deficient mice ( Fig. 5g ; systolic blood pressures were 129.5^1.5 mmHg for wild-type and 131:22
:4 mmHg for GPR91-deficient mice; heart rates were 613^12.4 beats min 21 for wild-type and 606^11.4 beats min 21 for GPR91-deficient mice). However, succinate could no longer induce hypertension in GPR91-deficient mice (Fig. 5h, i) . In contrast, angiotensin II increased blood pressure similarly in wild-type and Figure 5 The pro-hypertensive effect of succinate and GPR91. All results are shown as mean^s.e.m. Single asterisk, P , 0.05; double asterisk, P , 0.01; dagger, P . 0.05 (two-way analysis of variance or t-test). a, Plasma renin activity (PRA) in Sprague-Dawley rats by intravenous succinate infusion. GPR91-deficient mice (Fig. 5h, i) , indicating that the hypertensive effect of succinate might be mediated by GPR91. Succinate and a-ketoglutarate are normally present in mitochondria, but are found in circulation with mean plasma levels of about 5 mM for succinate and about 25 mM for a-ketoglutarate [14] [15] [16] . Succinate is known to increase the reabsorption of phosphate and glucose into the proximal tubule 17 and to stimulate gluconeogenesis 18 . Accumulation of extracellular succinate is observed in physiological and/or pathophysiological states linked to the deterioration of blood supply, such as ischaemia 19, 20 . It is known that the renovascular hypertension is often associated with restricted blood supply to the kidney owing to the obstruction of renal arteries in diseases such as atherosclerosis 5 . It is possible that the accumulation of succinate in ischaemic conditions might contribute to stenosisassociated hypertension through the activation of GPR91. Although we have shown that the hypertensive effect of succinate is mediated by GPR91 through the activation of the renin-angiotensin system, the molecular mechanism of renin release by succinate is not clear. Because GPR91 is a G q -and G i -coupled receptor, it is unlikely that GPR91 functions directly on the juxtaglomerular cells to stimulate renin release, which is usually triggered by G s activation 21 . It remains to be investigated whether sympathetic nerve activity, prostaglandins or nitric oxide 22 might provide an indirect mechanism for succinate-induced renin release. The presence of GPR91 in the liver and the spleen might also have functions in mediating these effects.
Thus, we have identified succinate as the natural ligand for GPR91, and a-ketoglutarate as the ligand for the homologous receptor GPR99. We have shown that intermediates in the citric acid cycle function as signalling molecules, engendering renewed interest in a biochemical pathway discovered more than 60 years ago. We have provided evidence that the pro-hypertensive effect of succinate is mediated by GPR91 and involves the renin-angiotensin system. GPR91 activation by succinate might therefore provide a link between energy homeostasis/metabolic status and haemodynamic regulation. The finding that intermediates in the citric acid cycle are GPCR ligands should facilitate the understanding of molecular links of the citric acid cycle to metabolic diseases, such as hypertension, atherosclerosis and diabetes, and the design of novel drugs with GPR91 and GPR99 as molecular targets. NMR and mass spectrometry C NMR spectra were recorded on a Bruker Avance DRX700 spectrometer (Bruker Analytik GmbH) at 700 and 176 MHz, respectively. The mass spectrum was obtained on an HP 1100MSD spectrometer (Agilent Technologies) with electrospray ionization in positive detection mode. A full-scan mass spectrum covering the m/z range 50-500 was acquired.
Cell culture and signalling assays
Chinese hamster ovary (CHO) cells were transiently transfected with 5 mg GPCR and 5 mg aequorin reporter gene 7 in 100-mm dishes as described 23 . Aequorin luminescence was recorded with a Microlumat (Berthold). FLIPR assays were performed on FLIPR384 with a FLIPR calcium assay kit (Molecular Devices). Inositol phosphate formation was assayed as the incorporation of 3 H-myo-inositol as described 23, 24 . Cells were stimulated with compounds in the presence of 10 mM LiCl for 40 min at 37 8C before the addition of 20 mM formic acid. cAMP assay was performed with the cAMP-Screen system (Applied Biosystems). Cells were stimulated for 20 min with 10 mM forskolin before treatment with compounds for a further 20 min at 37 8C. Anti-phospho-Erk and anti-Erk monoclonal antibodies were obtained from New England Biolabs. Anti-Flag and anti-tubulin antibodies were obtained from Sigma. Western blots were detected with the ECL Plus detection system (Amersham). For some studies, 100 ng ml 21 pertussis toxin (Calbiochem) was incubated with cells for 16 h.
Immunofluorescence staining
Human embryonic kidney 293 cells transfected with Flag-tagged GPR91 or GPR99 were plated on poly-(D-lysine)-treated slides. Cell-surface staining and ligand-induced internalization was performed as described 9 . Internalization of GPR91 or GPR99 was induced for 10 min by succinate (200 mM) or a-ketoglutarate (300 mM) at 37 8C.
In situ hybridization, immunohistochemistry and expression analysis These were performed as described 10, 25 .
[ 33 P]UTP-labelled antisense or sense RNA probes for mouse GPR91, GPR99 or renin were hybridized to paraformaldehyde-fixed, paraffinembedded mouse kidney sections. For periodic acid-Schiff and renin staining, adjacent mouse kidney sections were used. For co-localization with calbindin on the same tissue section, slides were incubated with anti-calbindin antibody (Sigma) and developed with Vectastain avidin-biotin-complex kit (Vector Lab) with 3,3 0 -diaminobenzidine as substrate before hybridization in situ. Sections were counterstained with haematoxylin or toluidine blue. Q-RT-PCR was performed on an ABI Prism 7700 sequence detector using Taqman Gold kit (Applied Biosystems). Ratios of GPR91 or GPR99 to glyceraldehyde-3-phosphate dehydrogenase mRNA were calculated. Primer and probe sequences for GPR91 and GPR99 are available from the authors on request.
Receptor model
The published bovine rhodopsin structure was used as a template for generating a partial GPR91 structure model 26 . The GPR91 primary sequence was aligned to bovine rhodopsin (PDB code 1F88; Supplementary Information), and the three-dimensional homology model was generated with the Modeller program.
In vivo experiments
All experiments were performed under protocols approved by the Institutional Animal Care and Use Committee. Animals were housed in a temperature-controlled room under a 12 h light-dark cycle with water and standard rodent chow available ad libitum. Blood pressure was measured in unanaesthetized animals by the tail-cuff method or in pentobarbitol-anaesthetized animals by the intra-arterial method for those involving chemical administration 27, 28 . Male Sprague-Dawley rats (about 300 g; Harlan) or mice (about 30 g; Lexicon) were used. Systolic blood pressure was recorded in mice for 5 days; at least 20 measurements were made daily with a BP-2000 blood pressure analysis tail-cuff system (Visitech Systems). The mean systolic blood pressure and pulse rate were taken for each animal. Intra-arterial measurement of blood pressure was achieved with a polyethylene PE50 (for rats) or a stretched PE10 (for mice) catheter implanted into the carotid artery, with another implanted into the jugular vein before the experiments. The artery catheter was connected to a high-sensitivity isometric transducer (Harvard Apparatus) for continuous recording of blood pressure. MAP data were acquired by Ponemch Physiology Platform (Gould Instrument). The venous catheter was used for chemical administration. Bilateral nephrectomy was performed as described 29 . Captopril (10 mg kg
21
) was given as a bolus injection 30 min before the administration of succinate. Plasma renin activity was determined by radioimmunoassay as the rate of angiotensin I generation (DiaSorin). GPR91-deficient mice were generated by homologous recombination in embryonic stem cells (Lexicon). Results are expressed as means^s.e.m. Statistical significance was evaluated by Student's t-test or two-way analysis of variance, followed by Dunnett's post-hoc test. Differences resulting in P , 0.05 were considered significant.
